Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain.
作者信息
Montero-Escribano Paloma, Matías-Guiu Jorge, Gómez-Iglesias Patricia, Porta-Etessam Jesús, Pytel Vanesa, Matias-Guiu Jordi A
机构信息
Department of Neurology, San Carlos Health Research Institute, Universidad Complutense.28040 Madrid, Spain.
Department of Neurology, San Carlos Health Research Institute, Universidad Complutense.28040 Madrid, Spain.
出版信息
Mult Scler Relat Disord. 2020 Jul;42:102185. doi: 10.1016/j.msard.2020.102185. Epub 2020 May 7.
Abstract
摘要
相似文献
1
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain.多发性硬化症及相关疾病中的抗CD20与COVID-19：来自西班牙马德里的60例患者病例系列
Mult Scler Relat Disord. 2020 Jul;42:102185. doi: 10.1016/j.msard.2020.102185. Epub 2020 May 7.
2
Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab.使用奥瑞珠单抗治疗的多发性硬化症患者中COVID-19的良性病程。
Mult Scler Relat Disord. 2020 Jul;42:102201. doi: 10.1016/j.msard.2020.102201. Epub 2020 May 15.
3
Anosmia in a healthcare worker with COVID-19 in Madrid, Spain.西班牙马德里一名感染新冠病毒的医护人员出现嗅觉丧失症状。
Travel Med Infect Dis. 2020 May-Jun;35:101666. doi: 10.1016/j.tmaid.2020.101666. Epub 2020 Apr 13.
4
Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19.抗CD20免疫抑制疾病改善疗法与新型冠状病毒肺炎
Mult Scler Relat Disord. 2020 Jun;41:102135. doi: 10.1016/j.msard.2020.102135. Epub 2020 Apr 18.
5
COVID-19 in Madrid.马德里的新冠疫情。
Br Dent J. 2020 Jun;228(11):812-813. doi: 10.1038/s41415-020-1730-4.
6
Response of the multiple sclerosis community to COVID-19.多发性硬化症群体对2019冠状病毒病的反应。
Mult Scler. 2020 Sep;26(10):1134-1136. doi: 10.1177/1352458520948748.
7
Lung ultrasound signs and cytokine profile in Covid-19 patients: a case series.新冠病毒肺炎患者的肺部超声征象与细胞因子谱：病例系列研究
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):8632-8634. doi: 10.26355/eurrev_202009_22799.
8
Trends in Psychiatric Emergency Department Visits Due to Suicidal Ideation and Suicide Attempts During the COVID-19 Pandemic in Madrid, Spain.西班牙马德里在新冠疫情期间因自杀意念和自杀未遂导致的精神科急诊科就诊趋势
J Clin Psychiatry. 2020 Sep 1;81(5):20l13419. doi: 10.4088/JCP.20l13419.
9
COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?新型冠状病毒肺炎与高效多发性硬化症疗法：一切照旧的时候到了吗？
Mult Scler. 2020 Sep;26(10):1267. doi: 10.1177/1352458520948211. Epub 2020 Aug 7.
10
COVID-19 will change MS care forever - No.新冠疫情将永远改变多发性硬化症的护理——不。
Mult Scler. 2020 Sep;26(10):1149-1151. doi: 10.1177/1352458520929971. Epub 2020 Jun 22.
引用本文的文献
1
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases.针对新冠病毒的信使核糖核酸疫苗作为其他人类传染病的开拓者
Vaccines (Basel). 2024 Dec 16;12(12):1418. doi: 10.3390/vaccines12121418.
2
COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece.希腊多发性硬化症患者的新冠疫苗接种与病程
J Clin Med. 2023 Aug 23;12(17):5460. doi: 10.3390/jcm12175460.
3
Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies.免疫缺陷患者中，mRNA疫苗与腺病毒载体新冠疫苗诱导的T细胞和抗体反应差异
J Allergy Clin Immunol Glob. 2023 May;2(2):100091. doi: 10.1016/j.jacig.2023.100091. Epub 2023 Mar 15.
4
COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective.新型冠状病毒肺炎与早期大流行、脓毒症及疫苗：历史视角
J Intensive Med. 2021 May 18;1(1):4-13. doi: 10.1016/j.jointm.2021.04.003. eCollection 2021 Jul.
5
Outcome of COVID-19 Infection in Patients With Multiple Sclerosis Who Received Disease-Modifying Therapies: A Systematic Review and Meta-Analysis.接受疾病修正治疗的多发性硬化症患者感染新冠病毒的结果：一项系统评价和荟萃分析
J Clin Neurol. 2023 Jul;19(4):381-391. doi: 10.3988/jcn.2022.0348. Epub 2023 Mar 13.
6
SARS-CoV-2 immunity and vaccine strategies in people with HIV.HIV感染者中的新型冠状病毒2型免疫及疫苗策略
Oxf Open Immunol. 2022 Aug 17;3(1):iqac005. doi: 10.1093/oxfimm/iqac005. eCollection 2022.
7
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid T cells expansion protocol for adoptive immunotherapy: A pilot study.BNT162b2 疫苗接种供体中刺突特异性免疫应答的持久性和快速 T 细胞扩增方案用于过继免疫治疗的研究：一项初步研究。
Front Immunol. 2023 Feb 2;14:1061255. doi: 10.3389/fimmu.2023.1061255. eCollection 2023.
8
Immune responses following COVID-19 infection in multiple sclerosis patients using immunomodulatory therapy.COVID-19 感染后使用免疫调节疗法的多发性硬化症患者的免疫反应。
Acta Neurol Belg. 2023 Oct;123(5):1885-1892. doi: 10.1007/s13760-022-02125-6. Epub 2022 Nov 4.
9
Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2.SARS-CoV-2 适应性免疫的动物模型及其应用前景。
Front Immunol. 2022 Sep 16;13:993754. doi: 10.3389/fimmu.2022.993754. eCollection 2022.
10
Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS).多发性硬化症（MS）患者在大流行阶段感染新冠病毒的预测因素。
Int J Prev Med. 2022 Jul 15;13:102. doi: 10.4103/ijpvm.IJPVM_480_20. eCollection 2022.
本文引用的文献
1
An Italian programme for COVID-19 infection in multiple sclerosis.一项针对多发性硬化症患者新冠病毒感染情况的意大利项目。
Lancet Neurol. 2020 Jun;19(6):481-482. doi: 10.1016/S1474-4422(20)30147-2. Epub 2020 Apr 30.
2
Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19.抗CD20免疫抑制疾病改善疗法与新型冠状病毒肺炎
Mult Scler Relat Disord. 2020 Jun;41:102135. doi: 10.1016/j.msard.2020.102135. Epub 2020 Apr 18.
3
Management of neurological care during the COVID-19 pandemic.2019冠状病毒病大流行期间的神经科护理管理
Neurologia (Engl Ed). 2020 May;35(4):233-237. doi: 10.1016/j.nrl.2020.04.001. Epub 2020 Apr 10.
4
The COVID-19 pandemic and the use of MS disease-modifying therapies.新冠疫情与多发性硬化症疾病修正疗法的使用
Mult Scler Relat Disord. 2020 Apr;39:102073. doi: 10.1016/j.msard.2020.102073. Epub 2020 Mar 27.
5
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia.B细胞在新冠病毒疾病中可能发挥的作用？来自无丙种球蛋白血症患者的启示。
J Allergy Clin Immunol. 2020 Jul;146(1):211-213.e4. doi: 10.1016/j.jaci.2020.04.013. Epub 2020 Apr 22.
6
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.两名 X 连锁无丙种球蛋白血症患者因 COVID-19 出现肺炎表现，但已康复。
Pediatr Allergy Immunol. 2020 Jul;31(5):565-569. doi: 10.1111/pai.13263. Epub 2020 May 19.
7
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?奥瑞珠单抗治疗多发性硬化症患者合并 COVID-19：免疫抑制是否具有保护作用？
Mult Scler Relat Disord. 2020 Jul;42:102120. doi: 10.1016/j.msard.2020.102120. Epub 2020 Apr 15.
8
Should we expect neurological symptoms in the SARS-CoV-2 epidemic?在新冠疫情中我们应该预期会出现神经症状吗？
Neurologia (Engl Ed). 2020 Apr;35(3):170-175. doi: 10.1016/j.nrl.2020.03.001. Epub 2020 Apr 6.
9
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.一个涉及 2019 年新型冠状病毒的家庭聚集性肺炎病例，提示存在人际传播：一项家庭聚集性研究。
Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.
10
Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients.从两名多发性硬化症患者的中枢神经系统组织中分离出两种冠状病毒。
Science. 1980 Aug 22;209(4459):933-4. doi: 10.1126/science.7403860.
Zotero 插件